Hyberbaric oxygen increases atresia in normal & steroid induced PCO rat ovaries by Alev Atis et al.
RESEARCH Open Access
Hyberbaric oxygen increases atresia in normal &
steroid induced PCO rat ovaries
Alev Atis1*, Yavuz Aydin2, Filiz Ciftci1, Damlanur Sakız3, Abdullah Arslan4, Akın S Toklu4, Melahat Donmez1 and
Nimet Goker1
Abstract
Background: In this study, we investigated the effect of hyperbaric oxygen therapy (HBOT) on the morphology of
estradiol valerate (EV) induced polycystic ovary (PCO) to find a new treatment modality for improvement of PCO.
Methods: The rats were divided into four groups. Group1, control; group 2, PCO group; group 3, PCO with HBOT
group and group 4, normal ovary with HBOT. PCO was induced by a single intramuscular injection of 4 mg EV in
adult cycling rats. Other rats with normal ovaries had oil injection as placebo. HBOT was applied to third and
fourth groups for six weeks. Histopathologic evaluation of ovaries of all groups were performed & compared.
Results: Six weeks of HBOT was resulted in increase in follicular atresia, decrease in the number of primary,
secondary, tertiary follicles and decrease in the number of fresh corpus luteum in normal rat ovary. HBOT on
polycystic rat ovary, resulted in significant increase in atretic follicles which were already present.
Conclusions: HBOT of six weeks itself, changed ovarian morphology in favor of atresia both in PCO group and
control group. This result of aggravated follicular atresia after HBOT on EV induced PCO may be due to long-term
exposure in our protocol which with this state seems to be inapplicable in the improvement of PCO morphology.
Keywords: Hyperbaric-oxygen, Polycystic-ovary, Rat, Estradiol valerate
Background
Polycystic ovary syndrome (PCOS), the most common
endocrinopathy in women of reproductive age is a mul-
tifactorial metabolic disease associated with insulin resis-
tance [1]. PCOS is a common condition with a range of
clinical features. These reproductive features include
anovulation, irregular menstrual cycles, clinical and bio-
chemical hyperandrogenism and infertility. Metabolic
features include increased risk factors for type 2 diabetes
mellitus and cardiovascular disease and increase in the
prevalence of the metabolic syndrome [1,2].
Previously, the diagnosis of PCOS was based on the
National Institute of Health (NIH) criteria comprising
biochemical or clinical hyperandrogenism and anovula-
tory irregular menstrual cycles with the exclusion of
related reproductive disorders. In 2003, diagnostic
guidelines for PCOS were expanded to the so-called
Rotterdam criteria, now based on presentation with any
two of the three criteria of hyperandrogenism, irregular
anovulatory periods or polycystic ovaries on ultrasound
[1,3]. The reported prevalence range of PCOS is
between 2.2% to 26% [1,3,4]. The wide range of esti-
mated PCOS prevalence can be explained by different
recruitment processes of the study populations, selection
biases, ethnic and racial variations in addition to, the
criteria used for its definition and the screening meth-
ods used to identify each criteria; considering the Rot-
terdam versus NIH criteria increase the PCOS
prevalence by 2 times. The latest study by Tehrani et al.
demonstrated that the prevalence’s of PCOS using the
NIH definition were 8.5% [4].
The abnormalities detected in PCOS have been attrib-
uted to primary defects in the hypothalamic-pituitary-
adrenal axis, the ovarian microenvironment, the adrenal
gland and the insulin/insulin-like growth factor meta-
bolic regulatory system [2,5]. There is evidence that
both hypothalamic and pituitary mechanisms contribute
to the gonadotropin dysfunction in PCOS.
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The reproductive systems of human beings and other
vertebrates are grossly similar [6]. Although the rat is a
polytocous rodent, the female has a regular ovarian
cyclicity of 4 or 5 days, with distinct proestrus, estrus,
and diestrus phases. PCO can be experimentally pro-
duced in the rat, that species is a good model for study-
ing the pathophysiology of human PCO by a single dose
of the long-acting estrogen, estradiol valerate (EV)
which leads to anovulatory state in 13-15 week-old rats
[6,7].
The therapeutic application of hyperbaric oxygen
(HBO) has been known over three decades in different
fields of medicine. Hyperbaric oxygen therapy (HBOT)
is defined by the Undersea and Hyperbaric Medical
Society (UHMS) as a treatment in which a patient inter-
mittently breathes 100% oxygen while the treatment
chamber is pressurized to a pressure greater than sea
level (1 atmosphere absolute, ATA). The therapeutic
principle behind HBO stems from increasing the partial
pressure of oxygen in the tissues of the body. The
effects of HBO are based on the gas laws, and the phy-
siological, biochemical effects of hyperoxia [8,9]. High
tissue levels of oxygen stimulate angiogenesis by increas-
ing the production of cytokines and many growth fac-
tors, especially VEGF. Because of these effects on
angiogenesis and hyperoxia, it is a unique method used
in the treatment of various illnesses and clinical condi-
tions, such as carbon monoxide poisoning, decompres-
sion sickness, osteomyelitis, even diabetic foot and
ischaemic wounds [9,10].
Besides, wound healing, HBOT has been used for
many clinical treatments. Previous experiments have
demonstrated that HBO improves survival in anesthe-
tized rats during heatstroke by reducing multiorgan dys-
function [11]. Furthermore, microarray analysis of gene
expression in rat cortical neurons exposed to HBO
showed that 17 genes changed in response to all expo-
sure conditions [12]. HBOT is also used for primary
liver nonfunction as it stimulated hepatocytes to prolif-
erate. Experimentally, HBO was found significantly
effective in the survival of transplanted cells or tissues
like liver, bone, thyroid, pancreatic islet cells [13].
Although a large proportion of ovarian follicles were
lost during the initial ischemia after transplantation of
ovaries, recently it was also found that HBO was also
beneficial for the follicular survival of the transplanted
mouse ovaries [14].
HBOT was also used in invitro-fertilisation (IVF)
protocols in different studies for improving ovarian
folicular stimulation and endometrial receptivity as an
adjunct to infertility therapies with the hypothesis of
increasing impaired follicular angiogenesis and oxyge-
nation and increasing pregnancy implantation by
improving endometrial receptivity by adequate
vascularisation and oxygenation in unexplained inferti-
lity patients respectively [15,16]. Although new; these
trials offer hopeful results for future infertility
patients.
Principal mechanisms of HBO are based on intracellu-
lar generation of reactive species of oxygen and nitrogen
by causing oxidative stress. Reactive oxygen species
(ROS) are recognized to play a central role in cell signal
transduction cascades or pathways, for a variety of
growth factors, cytokines, and hormones. Scavenging
antioxidants combat the overproduction of reactive spe-
cies like vitamine E and C, glutation [10,17]. Recently,
some new data about the role of oxidative stress and
antioxidants in modulation of ovarian techal-interstitial
cells have been enlightened. First, it was demonstrated
that antioxidants inhibited proliferation of theca-intersti-
tial cells then new findings added that antioxidants with
distinctly different mechanisms of action induce a series
of events consistent with the process of apoptosis in
ovarian mesenchyme [18,19]. As PCOS is a condition
associated with excessive growth and activity of theca-
interstitial cells, these findings bring the question of the
role of oxidative stress and antioxidants in PCO disease.
Treatment of human PCOS is symptomatic, lifestyle
measures such as diet and exercise (or both) could play
an important role in optimising healthy weight, improv-
ing underlying hormonal disturbances, prevention of
future reproductive and metabolic complications and
improving quality of life. Lifestyle interventions are
recommended first-line in an international position
statement on PCOS and present a cost effective initial
treatment strategy compared to surgical and pharmaco-
logical options [20]. In the recent Cochrane review the
positive effects of lifestyle treatment on anthropometric
(abdominal adiposity, adiposity distribution), reproduc-
tive (biochemical and clinical hyperandrogenism) and
metabolic features (markers of insulin resistance) were
confirmed with medium or long term lifestyle measures
[21].
In the present study, we tried to find a new, alterna-
tive treatment modality for PCO disease, considering
the different effects of hyperoxia on different tissues,
mentioned above. For this, we tested the hypothesis that
6 weeks of HBO administration on polycystic rat ovary
would make an improvement or reversal of PCO state.
This was carried out by studying the effect of HBO on
ovarian morphology including different folicular stages.
Methods
Animals
80 young, cyclic female Wistar-Albino rats (250-300 g)
were used for the experiment. All rats were provided by
Experimental Medicine Research Center (DETAM) of
Istanbul University and housed in the Animal
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Laboratory of the same centre. They were caged in a
controlled environment of 22°C with 12 h light/dark
cycles and a humidity range between 40 and 60%. Stan-
dard rat feed and reverse-osmosis-purified water were
provided ad libitum. All rats were allowed to have 1
week of acclimation to this environment before the
experiment. This study approved by ‘Animal Studies
Comittee’ at DETAM Unite of Istanbul University,
Istanbul and all investigations complied with the 1996
National Academy of Science’s Guide for Care and Use
of Laboratory. Eighty animals were divided into four
experimental groups: group 1, control (n = 20); group 2,
PCO only group (n = 20); group 3, PCO+HBO group (n
= 20) and group 4, HBO only group (n = 20).
PCO induction
Young cyclic Wistar females were taken and had free
access to pelleted rat food and water. All animals were
displaying at least 2 consecutive normal 4-day estrous
cycles were used in this study. Estrous cycles prior to
and after treatment were monitored by daily examina-
tion of vaginal smears.
To induce a well defined PCO, 4 mg im injection of
EV (Sigma, Riedeldehaen, Germany) was administered
in 0.2 ml of sesame oil. Forthy rats those in the PCO
groups received EV and the remaining rats (also in
estrus) those in the oil groups were injected 0.2 ml oil.
A duration of 6 weeks was chosen because a single
injection of EV induces, after a lag period of 4-6 week,
a chronic anovulatory PCO condition in adult rats
[6,7].
HBO
After full PCO state was obtained (after six weeks from
the EV or oil injection), the rats were allowed to take
six weeks of HBOT. We have chosen 6 weeks of HBOT
depending on protocols of Department of Underwater
and Hyberbaric Oxygen Unite for chronic diseases pro-
tocol for rats.
Hyperbaric Chambers and standard protocols used for
rats that is 2.5 atm pressure, totally 60 minutes once a
day protocol is used [8,9]. The chamber was ventilated
with 100% oxygen at a flow rate of 20 L/min to mini-
mize CO2 accumulation. Rats were then slowly decom-
pressed at a rate of 1 ATA/min at Istanbul University
Underseas and Hyperbaric O2 Department.
The rats were decapitated after HBOT finished, inde-
pendent of cycle day. Before decapitation, all rats were
anaesthetised with an i.p. administration 50 mg/kg keta-
mine hydrochloric acid (Ketalar; Eczacibasi Warner-
Lambert Ilac Sanayi, Levent, Istanbul, Turkey) and 7
mg/kg Xylazine hydrochloric acid (Rompun, Bayer Sisli,
Istanbul, Turkey)
Ovarian morphology and quantitative analysis of follicle
populations
Tissues
After death of one rat, rats were analysed, independent
of cycle day when full characteristic changes of ovaries
ensued, the ovaries were removed. Both ovaries were
weighed and fixed in buffered 4% formaldehyde for at
least 24 h. Thereafter, the samples were dehydrated and
embedded in paraffin to await morphological analyses
by the same author.
Only the number of follicles containing an oocyte with
a nucleus were classified as healthy and counted. If
ovum degeneration or at least one pyknotic granulosa
cell was observed, the follicle populations were classified
as being atretic. Primary and secondary follicles in each
section were enumerated only if the nucleolus of the
ovum was visible. The enumerated follicle was then clas-
sified as healthy or atretic. Primary follicles were
described as those having an intact, enlarged oocyte
with a visible nucleus and a single layer of cuboidal
granulosa cells. Secondary follicles were described as fol-
licles with two or more layers of cuboidal granulosa
cells, but formation of a cavity is not evident. Tertiary
or graafian follicles which was described as the presence
of an antral cavity within the follicle.
Quantification analyses were performed using 8-μm-
thick slices under light microscopy, adopting one section
and discarding ten sections in sequence and finally
resulting in 12 repetitions/ovary [22,23]. The primary,
secondary, tertiary antral and atretic follicles, fresh cor-
pora lutea were each counted that stained with haema-
toxylin and eosin on each ovary and numbers were
given per rat. All data were analyzed under a Zeiss
Axiophot II microscope (Carl Zeiss, Germany) using
20× magnification for primordial and primary follicles
and 10× for others.
Statistical analysis
All statistical evaluations were performed using the soft-
ware SPSS 15.0 (SPSS Inc., Chicago, USA). The effect of
the follicle counts of the ovaries after EV injection and/
or HBO on were evaluated using Kruskal Wallis test. p
< 0.05 was considered statistically significant. After
Kruskal Wallis, Mann Whitney-U test with Benforini
adjustment was applied.
Results
In control group (group 1), the ovaries exhibited a typi-
cally normal appearance with follicles and corpora lutea
in different stages of development and regression (Figure
1). The number of atresic follicles was significantly
lower and the numbers of fresh corpora luteas, tertiary
follicles, secondary follicles and primary follicles were
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significantly higher than other groups (Table 1 and
Table 2).
In PCO only group (group 2), the ovaries displayed
typical PCO-like changes (Figure 2); mean numbers of
tertiary, secondary and primary follicles were signifi-
cantly lower compared with the control group (Table 1
and Table 2). Typically, the number of atretic follicles
were significantly higher in the PCO only group
compared to control and very few fresh corpora lutea
was observed.
In the PCO+HBO group (group 3), there were signifi-
cantly higher atretic follicles (Figure 3) compared to the
Figure 1 Ovarian morphology in Control group.
Table 1 Comparison of mean numbers of follicles
Group 1 Group 2 Group 3 Group 4 p
AF 16.5 ± 3.7 25.4 ± 5,3 34.2 ± 8.2 29.1 ± 6.3 0.023
CL 13.5 ± 5.2 4.4 ± 3.6 3.1 ± 1,5 4.6 ± 4.2 0.002
TF 6.1 ± 2.6 2.4 ± 1.1 1.9 ± 0,8 2.1 ± 0.6 0.014
SF 13.5 ± 8.5 3.1 ± 0.9 3.2 ± 1.9 4.3 ± 0.5 0.004
PF 5.8 ± 2.3 1.6 ± 1.1 1.5 ± 1.3 1.6 ± 0.5 0.003
*p values of Kruskal-Wallis test
AF: atretic follicle, CL:fresh corpus luteum, TF: tertiary follicle, SF:secondary
follicle, PF: primary follicle.
Table 2 Comparison of p values of groups regarding
follicle types
P AF CL TF SF PF
Group 1/Group 2 0.028 0.021 0.012 0.008 0.013
Group 1/Group 3 0.011 0.004 0.002 0.012 0.021
Group 1/Group 4 0.024 0.034 0.003 0.019 0.003
Group 2/Group 3 0.037 NS NS NS NS
Group 2/Group 4 NS NS NS NS NS
Group 3/Group 4 NS NS NS NS NS
*p values of Mann Whitney-U test with Benforini adjustment for multiple
comparisons.
NS: nonsignificant
AF:atretic follicle, CL:fresh corpus luteum, TF:tertiary follicle, SF:secondary
follicle, PF:primary follicle
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PCO only group (p = 0.037). Although number of atretic
follicles in group 3 seems to be more than group 4, the dif-
ference was not statistically significant (Table 2).
In the only HBO group (Group 4), there were signifi-
cantly higher atretic follicles compared to group 1 (p =
0,024). There were significantly lower fresh corporea
lutea (p = 0,034) and healthy growing follicles (Table 2).
Although the number of atretic follicles were seems to
be higher (Figure 4), it did not differ significantly com-
pared with group 3.
Figure 2 Cystic Follicles of Polycystic ovary (PCO) group.
Figure 3 Atretic and cystic follicles in PCO+HBO group.
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Discussion
Cystic ovarian disease and/or PCOS are disorders of the
reproduction that affect bovine, ovine, caprine and por-
cine species and even human beings [1,2]. Several
experimental models for PCO have been developed in
rats; of these EV cause a sudden appearance of PCO
due to disturbances in metabolic and physiologic pro-
cesses [6,7].
Many studies were established such as electroacu-
puncture, hemohim, Korean red ginseng extract, herbal
medicine, exercise assessing the effect of different thera-
pies on EV induced PCOS rats [24-27]. Some of them
found improvement in ovarian morphology of PCO
state, and some of them did not. The difference of our
study from those is that; they investigated the inhibition
of PCO state starting therapies on the same day with
EV injection, but we wanted to investigate the improve-
ment in ovarian morphology of PCO state by starting
HBOT after PCO morphology was fully established,
rather than to investigate the inhibition of formation of
PCO morphology.
The application of HBO ensures a normal supply of
molecular oxygen to mitochondria, transported from the
lungs to the endometrial cells or to ovarian tissue in a
physically dissolved form in body fluids. Ultimately the
increases in dissolved oxygen generated by HBO have
several physiologic effects that can alter tissue responses
to disease and injury [8,15]. In our study, after PCO for-
mation, six weeks of HBO treatment, 60 minutes once a
day protocol did not reverse but in contrast, aggravated
the atresia of follicular growth in the rat ovaries, signifi-
cantly. HBOT of healthy rat ovary increased the young
follicular atresia and decreased the healthy growing folli-
cles and also decreased the fresh corporea lutea signifi-
cantly. The mean number healthy growing follicles were
found lower than control and PCO groups but similar
with PCO+HBO group. So this forced us to think that
HBO administration created the same effect on ovarian
histology like EV. Significantly, the mean number of
atresia was higher in HBO+PCO group compared to
PCO group, we think that the accelerated atresia is due
to HBOT and HBO did not help to improve PCO state
in the ovaries but inspite aggravated it. When we
reviewed our results with rat studies about HBOT, we
came to know that HBO administration also led to
unwelcome side-effects, such as oxidative stress and/or
oxygen toxicity, the formation of ROS can cause cellular
damage through the oxidation of lipids, proteins and
DNA [28]. One study assessing oxidative stress levels in
rats following exposure to oxygen at 3 atm for 0-120
minutes exhibited a clear relationship of HBO-induced
oxidative action to exposure time. This action was most
pronounced from 90 to 120 minutes of exposure [29].
Another study on the effects of HBO in rats revealed
that after 2 hours of HBO exposure at 3 ATA, levels of
the oxidative stress markers elevated in lung, brain and
erythrocytes [30]. Repetitive treatment with HBO was
proved to cause oxidative stress in critical tissues
Figure 4 Marked atretic follicles in HBO group.
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including the rat brain, lymphocytes. Malondialdehyde
levels and other oxidative stres markers were found to
be significantly increased in the therapies after 20 day to
40 day session groups [31]. Although HBO-mediated
free radicals were accepted to be responsible for the
benefits of this therapeutic modality, especially in cases
with prolonged exposure, possible injurious effects of
supranormal values of bio-oxidative products need to be
considered. Our application of 6 weeks HBO might be
too much regarding exposure time and duration of it for
PCO rats which is a multi-system disease that already
carries underlying metabolic pathologies. Confirming
this, Takahashi et al. found a biphasic effect of the gen-
eration of superoxide radicals on proliferation consistent
with the concept that while moderate oxidative stress
may induce cell growth, very high levels of ROS were
cytotoxic and led to cell, tissue damage and apoptotic
cell death [32]. Although we did not measure oxidative
stress markers, all these aforementioned data may help
to explain why we found aggrevation of atresia rather
than reversal of it. As we did not measure the VEGF
levels we can’t declare clearly if modulated mechanisms
of angiogenesis were causative.
Although human PCO is not the same as rat model,
the oxidative effects of HBO have been investigated
both in animals and human [29,30]. The protocols are
consistent with the principles of partial pressures reach-
ing that tissue. Henry’s law states that the amount of
gas dissolved in a liquid or tissue is proportional to the
partial pressure of that gas in contact with the liquid or
tissue. This is the basis for increased tissue oxygen ten-
sions with HBOT [8,9].
The clinically approved maximum pressure and dura-
tion of HBO exposure are 3 ATA and 120 minutes,
respectively although the most commonly-used protocol
for standard therapeutic purposes is slightly lower (1.8-
2.8 ATA for 60-90 min) [9,28]. We applied chronic dis-
eases standard HBO protocol (2.5 atm, 60 minute once a
day) for our rat PCO model, considering the PCO as
multi-systemic and chronic disease. Treatment recom-
mendations mentioned in this paper are taken from the
UHMS report and are evidence-based [8]. Protocols vary
greatly, but the UHMS recommend treatments beginning
at 2.0-2.5 ATA for up to 120 minutes at least once a day
until no improvement in diseases are reached. When we
reviewed rat HBO studies, we found there were different
protocols like 2 atm, 2.8 atm/90 min for 5-40 days or 3
atm for up to 120 minutes, although guidelines vary
depending on the injury [28-31]. It would be more
favourable for our study if we could apply different pres-
sures and different exposure time and analyze their
effects. This will be our goal for future studies.
There is a substantial body of literature that has
examined the adverse and beneficial effects of HBOT in
animal models. As technology becomes more readily
available to clinical practice and more clinical trials are
performed to define its effectiveness, HBOT may be
considered as an additional therapeutic option in many
conditions. Recent studies assessed the role of HBOT in
unsuccessful IVF protocols or endometrial implantation
failures and found convincing results although the stan-
dard protocols are not yet established. We tried to find
an alternative or adjunctive treatment modality for
PCO. Depending on the tissue concentration it can
either exert beneficial physiologic effects or damage cell
structures. We suggest that our present HBO protocol
is not applicable for treatment of PCO disease and that
should be considered in infertility patients with PCO;
but may be rearranged accordingly in rat PCO model
which needs further studies.
Quantifying the follicles may be time consuming and
not an easy way of assessing ovarian histology, this is an
experimental study and we wanted to assess the details
of ovarian morphology other than ovulation [22,23].
Our study is the first that HBO is used in EV induced
PCO rats and control rats. Our study is privileged from
others that, the long- term effect of HBO on PCOS was
demonstrated. To our knowledge, there is no study in
the literature evaluating the effect of HBOT on PCO.
Conclusions
We conclude that in our experimental rat model, HBOT
did not improve or reverse the PCO state in EV induced
PCO rat ovaries, in contrast, after HBOT, follicular atre-
sia increased significantly. With this protocol it seems
unfavorable to administrate HBOT in PCO state.
Further studies are needed to identify the accompanying
factors of this result like exposure time or duration of
therapy
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